What is Emergent Biosolutions's cash ratio?

Emergent Biosolutions (EBS) reported cash ratio of 1.1× in Q1 2026.

How has Emergent Biosolutions's cash ratio changed year-over-year?

Emergent Biosolutions's cash ratio decreased by 20.5% year-over-year, from 1.4× to 1.1×.

What is the long-term trend for Emergent Biosolutions's cash ratio?

Over 5 years (2020 to 2025), Emergent Biosolutions's cash ratio has grown at a -0.4% compound annual growth rate (CAGR), from 1.6× to 1.6×.

What does cash ratio mean?

Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.

Emergent Biosolutions EBS Cash ratio

Cash ratio at other companies

Thermo Fisher ScientificTMO

0.2×-0.1×

Regeneron PharmaceuticalsREGN

0.6×-0.3×

AMP

Amphastar PharmaceuticalsAMPH

1×+0.1×

Amneal Pharmaceuticals, Inc.AMRX

0.3×+0.2×

CorMedixCRMD

1.4×-0.5×

Collegium Pharmaceutical, Inc.COLL

0.7×+0.4×

Other financials

Income statement

See full

Revenue$156.1M-29.7%

Gross profit$84.1M-37.1%

Operating income$10.5M-79.0%

Net income$6.8M-90.0%

EPS (diluted)$0.07-94.1%

Balance sheet

See full

Cash & equivalents$161.5M+5.7%

Total debt$584.6M-13.1%

Total equity$523.1M-5.4%

Total assets$1.3B-7.4%

Cash flow

See full

Operating cash flow-$33.8M-202%

CapEx$2.4M-33.3%

Free cash flow-$36.2M-145%

Valuation

See full

Market cap$411.74M+22.0%

Enterprise value$834.84M-2.6%

P/E3.6×—

P/S0.6×+0.3×

Profitability

See full

Gross margin54.2%+19.0pp

Operating margin15%+10.3pp

Net margin9.6%+5.8pp

FCF margin20.8%—

Returns & leverage

See full

Return on equity13.9%+8.1pp

Debt / equity1.1×-0.1×

Current ratio4.3×-2.0×

Where this comes from

Calculated from Emergent Biosolutions’s reported figures.

cash and equivalents/total current liabilities=1.1×

Based on the most recent quarter.

The official record: Emergent Biosolutions’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Emergent Biosolutions's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Emergent Biosolutions's cash ratio?: Emergent Biosolutions (EBS) reported cash ratio of 1.1× in Q1 2026.
How has Emergent Biosolutions's cash ratio changed year-over-year?: Emergent Biosolutions's cash ratio decreased by 20.5% year-over-year, from 1.4× to 1.1×.
What is the long-term trend for Emergent Biosolutions's cash ratio?: Over 5 years (2020 to 2025), Emergent Biosolutions's cash ratio has grown at a -0.4% compound annual growth rate (CAGR), from 1.6× to 1.6×.
What does cash ratio mean?: Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.